Back
OrthoPediatrics 10K Form
Sell
25
KIDS
OrthoPediatrics
Last Price:
$22.70
Seasonality Move:
3.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-06 | 10Q | KIDS/OrthoPediatrics Quarterly |
2020-05-06 | 10Q | KIDS/OrthoPediatrics Quarterly |
2020-03-05 | 10K | KIDS/OrthoPediatrics Annual |
2019-11-08 | 10Q | KIDS/OrthoPediatrics Quarterly |
2019-08-13 | 10Q | KIDS/OrthoPediatrics Quarterly |
2019-05-09 | 10Q | KIDS/OrthoPediatrics Quarterly |
Receive KIDS News And Ratings
See the #1 stock for the next 7 days that we like better than KIDS
KIDS Financial Statistics
Sales & Book Value
Annual Sales: | $148.7M |
---|---|
Cash Flow: | $-11.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $15.32 |
Price / Book: | 1.48 |
Profitability
EPS (TTM): | -1.23000 |
---|---|
Net Income (TTM): | $-28.4M |
Gross Margin: | $111.3M |
Return on Equity: | -7.63% |
Return on Assets: | -6.38% |
OrthoPediatrics Earnings Forecast
Key OrthoPediatrics Financial Ratios
-
The Gross Profit Margin over the past 10 years for KIDS is 74.80%.
-
The Selling, General & Administrative Expenses for KIDS have been equal to 85.27% of Gross Profit Margin.
-
The Research & Development expenses have been 6.86% of Revenue.
-
The Interest Expense is 192.69% of Operating Income.
-
The Net Earning history of KIDS is -14.10% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 6 years.
OrthoPediatrics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | KIDS |
CUSIP: | 68752L |
Website: | orthopediatrics.com |
Debt
Debt-to-Equity Ratio: | 0.2 |
---|---|
Current Ratio: | 7.17 |
Quick Ratio: | 3.43 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
KIDS Technical Analysis vs Fundamental Analysis
Sell
25
OrthoPediatrics (KIDS)
is a Sell
Is OrthoPediatrics a Buy or a Sell?
-
OrthoPediatrics stock is rated a SellThe current OrthoPediatrics [KIDS] share price is $22.62. The Score for KIDS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.